← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2017Last known activity
Feb 6, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 6 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Indications
Recent trials (17)
- NCT05752201OfficialPhase 2/Phase 3Feb 6, 2023
- NCT05752201Lead sponsorPhase 2/Phase 3Feb 6, 2023
- NCT05752201Overall official - principal investigatorPhase 2/Phase 3Feb 6, 2023
- NCT05752201Reponsible party - principal investigatorPhase 2/Phase 3Feb 6, 2023
- NCT05752201Sponsor investigatorPhase 2/Phase 3Feb 6, 2023
- NCT04521322Lead sponsorPhase 4Jul 24, 2020
- NCT04521322CollaboratorPhase 4Jul 24, 2020
- NCT04521322Sponsor investigatorPhase 4Jul 24, 2020
- NCT04521322Study directorPhase 4Jul 24, 2020
- NCT04395105Reponsible party - principal investigatorPhase 3May 18, 2020
- NCT04395105Overall official - principal investigatorPhase 3May 18, 2020
- NCT04395105Lead sponsorPhase 3May 18, 2020
- NCT04383535Overall official - principal investigatorN/AMay 15, 2020
- NCT04535063Lead sponsorPhase 3Apr 18, 2020
- NCT04535063Reponsible party - principal investigatorPhase 3Apr 18, 2020
Details
- Last known activity
- Feb 6, 2023